In this episode of The Healthy Enterprise Podcast, Gautham Pasupuleti, CEO and Co-founder of Biodesign Innovation Labs, shares his journey in the medical device industry and the role of personal experiences in shaping innovation. He discusses challenges in healthcare entrepreneurship, the impact of mentorship and community, and his focus on AI and precision medicine, especially in cancer treatment, offering advice for aspiring entrepreneurs.

Chapters:

00:00 Introduction to Biodesign Innovation Labs

02:47 Innovative Medical Devices for Critical Care

05:50 AI and Precision Medicine in Cancer Care

08:48 The Journey of Entrepreneurship in Healthcare

12:05 Personal Experiences Shaping Innovation

14:56 Building a Team and Community Engagement

17:51 The Role of Mentorship and Collaboration

21:07 Navigating the Healthcare Ecosystem

23:56 Advice for Aspiring Innovators

29:21 Journey into Medical Device Innovation

32:53 Overcoming Personal Tragedy and Professional Challenges

35:46 The Importance of Team Dynamics in Medical Innovation

39:28 Leadership Lessons from Personal Loss

44:37 Future Aspirations in Cancer Treatment and AI

48:19 Advice for Aspiring Entrepreneurs

Guest Information:

• Guest's Name: Gautham Pasupuleti
• Guest's Title/Position: Co Founder & CEO
• Guest's Linkedin:https://www.linkedin.com/in/gautham-pasupuleti-84884054/
• Company / Affiliation: Biodesign Innovation Labs https://biodesigninnovationlabs.com/
• Guest's Bio: Gautham Pasupuleti is the CEO and Managing Director of Biodesign Innovation Labs, a Bangalore- and Delaware-based medical device and healthcare company developing innovative and affordable critical care solutions. He leads a multidisciplinary team focused on life-saving technologies, including the patented RespirAID device, which supported hospitals across India during COVID-19. Gautham is a recognized innovator, having received awards such as Forbes India’s Ultimate 120 Pioneers of Change, the CISCO Global Problem Solver Pandemic Response Prize, and the Best Campus Startup Innovation Award from IIT Bombay. Previously, he was a researcher at MIT Media Lab and founded CornealX, an AI-based eye care startup now integrated into Biodesign Innovation Labs.

Takeaways:

• Biodesign Innovation Labs focuses on life-saving medical devices.
• Respirate is an automated solution for manual ventilation.
• The company started its journey in 2017 with a focus on critical care.
• Personal experiences can drive innovation in healthcare.
• Community engagement is crucial for understanding healthcare needs.
• Mentorship plays a significant role in entrepreneurial success.
• AI solutions are being developed for early cancer detection.
• Building a team with diverse skills is essential for success.
• Hands-on experience is vital for understanding real-world problems.
• Workshops and seminars can provide valuable insights and connections. Gautham's journey began with a desire to innovate in medical technology.
• He collaborated on a VR and AR device for children's eye exams.
• After his brother's passing, he took on significant responsibilities in their startup.
• The importance of innovation in medical devices cannot be overstated.
• Team dynamics and diverse skill sets are crucial for success.
• Personal experiences can drive motivation to solve meaningful problems.
• Leadership requires making tough decisions and trusting your instincts.
• Gautham learned valuable lessons from his brother's mentorship.
• Resilience and persistence are key traits for entrepreneurs.
• Networking with experienced individuals can provide valuable insights. 

In this episode of the Healthy Enterprise podcast, Kevin Harris, President of CureMetrix, shares his journey in tech and the co-founding of CureMetrix, a company using AI to improve breast cancer detection through mammography. He discusses the role of breast arterial calcifications in health, the integration of AI in radiology, and the regulatory and cultural challenges of advancing AI in healthcare. Kevin also highlights leadership, mentorship, education, and strategies for growing a successful healthcare technology company, as well as the evolving opportunities AI brings to women’s health and healthcare professionals.

Chapters:
00:00 Introduction to AI in Healthcare
03:49 The Genesis of CureMetrix
09:10 Challenges in Mammography
14:58 Innovations in Breast Cancer Detection
21:10 Leadership and Team Dynamics at CureMetrix
26:19 Building a Professional Culture
27:37 Challenges in AI Adoption
31:24 Navigating Regulatory Hurdles
34:40 Sales Strategies in a Niche Market
39:02 AI's Role in Women's Healthcare
42:04 Opportunities in Healthcare Careers

Guest Information:

• Guest's Name: Kevin Harris
• Guest's Title/Position: President and co-founder 
• Guest's Linkedin: https://www.linkedin.com/in/kevindavidharris/
• Company / Affiliation: CureMetrix https://curemetrix.com/
• Guest's Bio: Kevin Harris is the President and co-founder of CureMetrix. With over 25 years of leadership experience, Harris brings a demonstrated track record of success with particular expertise in new product ideation, implementation, market creation, and launch. As a strategic leader with deep operational expertise, Harris has led companies from inception through fundraising and mergers and acquisitions.  At CureMetrix, Harris is responsible for envisioning the AI-based products and services tied to breast cancer and breast arterial calcifications detection that are the foundation of the company’s business and are the first of their kind in the world.

Takeaways:

• Kevin Harris has over 35 years of experience in technology.
• CureMetrix was founded to leverage AI in healthcare.
• The company focuses on improving mammography outcomes.
• Breast arterial calcifications can indicate serious health issues.
• AI can help reduce false positives in mammography.
• CureMetrix's software provides valuable insights to radiologists.
• Collaboration with data scientists is crucial for innovation.
• Building a strong team and mentorship is key to success.
• Understanding the healthcare landscape is essential for leaders.
• Patient outcomes can be significantly improved with AI. Building a company culture of professionalism reduces drama.
• AI is perceived as a tool rather than a replacement for doctors.
• AI operates consistently without human limitations.
• Regulatory challenges are significant in bringing AI to market.
• Sales strategies must target the right decision-makers in healthcare.
• Education is crucial for the adoption of AI in healthcare.
• AI can help radiologists focus on more critical cases.
• There are opportunities to automate certain healthcare tasks safely.
• AI can assist in pre-reading medical images to save time.
• The healthcare system needs to improve public education on health issues.

In this episode of The Healthy Enterprise, Anna Forsythe, founder and CEO of Oncoscope-AI, shares her journey from manually processing oncology data to creating an AI-powered platform that delivers real-time treatment insights, clinical guidelines, and research to support oncologists in an ever-evolving cancer landscape. She discusses the importance of reliable evidence in decision-making, the positive response from physicians using the free platform, and the role of systematic data reviews in building trust and efficiency. Beyond the technology, Anna reflects on her entrepreneurial path, the challenges and opportunities of leading in healthcare, and the importance of cultivating talent, mission-driven culture, and visionary leadership. The conversation concludes with her insights on business models, community impact, and the future of AI in advancing cancer care.

Chapters:

00:00 Introduction to Oncoscope-AI and Anna Forsythe

03:04 The Need for Real-Time Oncology Data

05:59 Transitioning from Manual to Automated Data Processing

09:11 The Role of AI in Oncology

12:13 Feedback and Response from Healthcare Professionals

14:45 Data Sources and Systematic Reviews in Oncology

18:02 Future Developments and Expanding Services

21:53 AI in Research: Balancing Trust and Efficiency

25:52 Business Model and Revenue Streams

29:44 Personal Journey and Altruism in Business

32:56 Challenges and Opportunities in Healthcare

35:34 Leadership and Team Dynamics

39:29 Visionary Leadership and Future Aspirations

Guest Information:

• Guest's Name: Anna Forsythe
• Guest's Title/Position: Founder & CEO
• Guest's Linkedin: https://www.linkedin.com/in/anna-forsythe-3667143/ 
• Company / Affiliation:  Oncoscope-AI https://oncoscope-ai.com/ 
• Guest's Bio: Anna Forsythe, PharmD, MBA, is the Founder and CEO of Oncoscope-AI, the first platform to unify real-time oncology treatment data, clinical guidelines, research, and regulatory approvals—offered free to oncology professionals worldwide and often described as “Expedia for cancer care.” With a background spanning pharmacy, health economics, and executive leadership at Novartis, Bayer, and Eisai, Anna previously co-founded Purple Squirrel Economics (acquired by Cytel in 2020), has taught health economics at Long Island University, and is a frequent industry speaker and author, with her 2022 JAMA Pediatrics article on conversion therapy ranked in the top 5% of all JAMA research outputs worldwide.

Takeaways:

• Anna Forsythe is the founder and CEO of Oncoscope AI.
• Oncoscope AI provides real-time oncology treatment data and clinical guidelines.
• Doctors are overwhelmed with the volume of new evidence and guidelines.
• The platform aims to simplify access to oncology data, similar to Expedia for travel.
• AI is used to automate data processing but has limitations in consistency and accuracy.
• The platform is currently free for doctors to encourage adoption.
• Feedback from healthcare professionals is shaping the development of the platform.
• Data is sourced from publicly available databases like PubMed and clinical trials.
• The platform is expanding to include more cancer types and features.
• The response from users has been overwhelmingly positive, with over a thousand sign-ups. AI has a 0.2% error rate, necessitating careful review.
• A standardized database enhances research efficiency.
• The business model aims for profit while providing value.
• Personal experiences shape the desire to help others.
• Gathering data from doctors can lead to significant advertising revenue.
• The speaker is focused on launching multiple cancer treatments.
• Trust and transparency are crucial in AI innovation.
• Working with young talent is fulfilling and beneficial.
• Challenges in scaling the business are common in startups.
• Visionary leadership requires prioritization and focus.

In this episode, Sarah Bellenger, nurse veteran and entrepreneur, shares her journey creating Manage You, an app designed to fix inefficiencies in healthcare credentialing. She discusses the challenges of launching tech in a traditional industry, overcoming skepticism, and the importance of innovation and female leadership in healthcare. Sarah also reflects on funding disparities for women entrepreneurs and her vision for Manage You’s future impact on the industry.

Chapters

00:00 Introduction to Sarah Bellenger and Manage You

03:07 The Need for Credentialing Solutions

05:53 The Development Journey of Manage You

08:48 Challenges in Healthcare Credentialing

12:06 The App's Features and User Experience

14:58 Expanding Manage You's Reach

18:03 Future Developments and Scalability

20:58 Entrepreneurial Insights and Challenges

23:51 The Role of Women in Entrepreneurship

26:47 Vision for the Future of Credentialing

30:00 Conclusion and Call to Action

Guest Information:

• Guest's Name: Sarah Bellenger
• Guest's Title/Position: Founder & Chief Executive Officer
• Guest's Linkedin: https://www.linkedin.com/in/sarahrbellenger/
• Company / Affiliation: Manage You App https://www.manageyouapp.com/
• Guest's Bio: Sarah Bellenger is a clinician, Army veteran, and healthcare leader with over two decades of experience in patient care, team leadership, and system-wide operations. Her career spans cardiac ICU nursing, managing anesthesia teams across the U.S. and abroad, and even supporting executive health at the White House. After earning her MBA and serving in multiple leadership roles, Sarah recognized a recurring problem: capable professionals were burning out—not from the work itself, but from the inefficiencies surrounding it.
  Driven by her own experiences, including losing critical credentials during frequent relocations, Sarah founded Manage You—a mobile app that helps healthcare professionals and teams centralize documents, track deadlines, and simplify renewals. Her mission is clear: to reduce administrative burdens so clinicians can focus on what matters most—caring for patients.

Takeaways:

• Sarah Bellenger is a nurse veteran and entrepreneur.
• Manage You addresses the inefficiencies in the credentialing process.
• Credentialing is a $39 billion industry with significant waste.
• The app allows users to store and manage their credentials efficiently.
• Users receive reminders for expiring documents directly on their phones.
• The app is designed to be user-friendly and secure.
• Sarah emphasizes the importance of networking and mentorship in entrepreneurship.
• Women face unique challenges in securing venture capital funding.
• The future of credentialing may involve digital verification and AI.
• Sarah is committed to making healthcare credentialing more efficient.

In this episode of The Healthy Enterprise, host Heath talks with Erin Morrow, Director of Product Management at Embark Veterinary, about how genetics and AI are transforming pet health. Erin shares her journey into product management, the role of dog DNA in better care decisions, and the challenges of building products in a fast-moving startup. She also dives into the integration of AI at work, the power of customer feedback, and creative marketing strategies—including collaborations with Disney. The conversation wraps with advice for aspiring professionals and a look at the future of technology in pet care.

Chapters:
00:00 Introduction to Embark Veterinary and Its Mission
03:04 Erin Morrow's Journey and Background
05:57 Understanding Dog DNA and Its Impact on Care
09:03 The Role of Technology in Pet Care
12:00 Future Innovations in Pet Health and AI
14:59 Challenges in Product Development and Strategy
17:55 The Value of Fractional Leadership
20:49 Customer Feedback and Engagement Strategies
26:49 Embracing AI in the Workplace
30:12 Navigating Marketing Strategies
38:41 Innovative Collaborations in Pet Care
43:50 Advice for Aspiring Professionals

Guest Information:

• Guest's Name: Erin Morrow 
• Guest's Title/Position: Director of Product Management
• Guest's Linkedin: https://www.linkedin.com/in/erin-morrow-68336829/
• Company / Affiliation: Embark Veterinary https://embarkvet.com/
• Guest's Bio: Erin Morrow is the Director of Product at Embark Veterinary, where she combines her passion for animals with cutting-edge technology to revolutionize pet care. With over 15 years of experience, she specializes in taking innovative products from initial concept through commercialization across SaaS, biotech, and educational technology sectors. Erin has a proven track record of building high-performing teams that consistently deliver products that users genuinely love. Her unique background includes a Bachelor's in Animal Science and Master's in Conservation Biology, giving her both the scientific rigor and deep empathy for animals and their caretakers that drives her customer-focused approach to product development.

Takeaways:

• Embark Veterinary focuses on using genetics to enhance dog health.
• Erin Morrow has a diverse background in product management and animal science.
• Understanding a dog's DNA can significantly impact care decisions.
• The company has tested over 2 million dogs worldwide.
• AI and genomics are key to future pet health innovations.
• Customer feedback is crucial for product development.
• Fractional leadership can provide valuable insights and direction.
• Engaging with customers through social media enhances feedback.
• The importance of transitioning to a product-led organization.
• Continuous improvement in product offerings is essential for growth. 
• We're starting to use AI internally and for customer-facing features.
• If you're writing an email, use ChatGPT for assistance.
• You still need to check your work; you are the subject matter expert.
• Finding the right tools is complex; experiment with different options.
• Word of mouth is still our strongest marketing engine.
• We collaborated with Colossus for our commercials.
• Our partnership with Disney was a significant campaign.
• We track brand awareness through customer feedback.
• Collaborations in the pet care space are yielding positive results.
• Follow your passion, but stay open-minded in your career. 

In this episode, Dr. Harsha Rajasimha discusses his journey as a biotech entrepreneur and the founder of Jeeva Clinical Trials. He shares insights into the inefficiencies of traditional clinical trials and how AI can streamline the process, making it more efficient and accessible. The conversation also touches on the importance of inclusivity in clinical research, the role of AI agents, and the personal motivations behind his work. Dr. Rajasimha emphasizes the need for a unified platform to enhance collaboration and reduce complexity in clinical trials, ultimately aiming to improve patient outcomes.

Chapters:

00:00 Introduction to Jiva Clinical Trials and Harsha Rajaseema

02:50 The Clinical Trial Process: Challenges and Innovations

05:51 AI in Clinical Trials: Enhancing Efficiency and Security

08:59 The Role of AI Agents in Clinical Research

11:55 Addressing Inequities in Clinical Trials

15:02 Philanthropy and Patient Advocacy in Rare Diseases

18:08 The Journey of an Entrepreneur: Insights and Advice

Guest Information:

• Guest's Name: Dr. Harsha K. Rajasimha
• Guest's Title/Position: Founder & Chief Executive Officer
• Guest's Linkedin: https://www.linkedin.com/in/harsharajasimha/
• Company / Affiliation: Jeeva Clinical Trials https://jeevatrials.com/
• Guest's Bio: Dr. Harsha K. Rajasimha is a scientist, entrepreneur, and patient advocate, and the Founder & CEO of Jeeva Clinical Trials—an AI-driven platform making clinical research more efficient and accessible worldwide. He also serves as Founder and Chair of the Indo US Organization for Rare Diseases, building global collaboration to improve outcomes for patients with rare conditions. Motivated by personal loss, Harsha has dedicated his 20-year career in precision medicine and biotech to advancing rare disease research, patient advocacy, and the use of technology to accelerate clinical trials.

Takeaways:

• Dr. Harsha Rajasimha is the founder of Jeeva Clinical Trials.
• Clinical trials typically take 8-10 years to complete.
• AI can significantly reduce the time and cost of clinical trials.
• The current clinical trial infrastructure is complex and fragmented.
• Jeeva aims to unify the clinical trial process with a single platform.
• AI agents will automate repetitive tasks in clinical trials.
• Inclusivity in clinical trials is crucial for diverse patient representation.
• Philanthropy plays a key role in Dr. Rajasimha's mission.
• The platform supports over 100 languages for global accessibility.
• Community support is essential for entrepreneurial success.

In this episode, Bill Wittmeyer discusses his journey as the CEO of Maggie's Breath, a company focused on using breath analysis for early detection of breast cancer. He shares insights into the technology behind breath analysis, the importance of early detection, and the challenges faced in the healthcare industry. Bill also reflects on the personal impact of breast cancer in his life and the future plans for Maggie's Breath, including clinical trials and funding efforts.

Chapters:
00:00 Introduction to Bill Wittmeyer and Maggie's Breath
03:04 The Journey to Breath Analysis Technology
05:55 The Importance of Early Detection in Breast Cancer
08:56 Innovative Screening Methods and Their Implications
11:49 The Role of Metabolic Compounds in Disease Detection
15:05 Challenges in Implementing New Screening Technologies
18:01 Mobile Screening Solutions for Breast Cancer
20:59 Future Directions and Global Health Implications
26:55 Clinical Trials and Market Opportunities
30:02 Innovative Screening Technologies
34:04 Navigating Regulatory Challenges
36:10 The Journey of a Startup Founder
41:45 Personal Loss and Legacy
49:30 Fundraising and Community Engagement

Guest Information:

• Guest's Name: Bill Wittmeyer
• Guest's Title/Position: Founder & Chief Executive Officer
• Guest's Linkedin: https://www.linkedin.com/in/bill-wittmeyer-b0628a/
• Company / Affiliation: Maggie's Breath https://www.maggiesbreath.com/ 
• Guest's Bio: Bill Wittmeyer is the Founder and CEO of Maggie’s Breath (formerly Pulmostics Limited) where he applies advanced detection technologies—such as high-speed gas chromatography—to protect human health and the environment. Maggie’s Breath was renamed in honour of Bill’s late wife, Maggie, who lost her battle with breast cancer while working to advance life-saving diagnostics. Her vision lives on through the company’s mission: to create a revolutionary, non-invasive breath-based screening tool that can detect disease early and save lives. Bill’s leadership spans innovations in healthcare, environmental monitoring, and public safety, all driven by a commitment to turning personal loss into global impact for a healthier, more sustainable world.

Takeaways:
-Bill Wittmeyer is the CEO of Maggie's Breath, focused on breath analysis for breast cancer detection.
-Maggie's Breath aims to provide a non-invasive screening tool for breast cancer.
-The technology can analyze breath samples in just one minute.
-Breast cancer is increasingly affecting younger women, necessitating early detection methods.
-Current mammogram practices may not be effective for women with dense breast tissue.
-Breath analysis could complement existing mammogram technologies.
-The goal is to provide diagnostically actionable information at the point of care.
-Maggie's Breath was named in honor of Bill's late wife, who passed away from breast cancer.
-The company is seeking funding and partnerships to conduct clinical trials in Mexico.
-Bill emphasizes the importance of early detection in improving survival rates and reducing treatment costs. 

In this episode, Dr. Steve Schutzer shares his journey from a Bronx kid to a prominent orthopedic surgeon and co-founder of Upswing Health. He discusses the importance of improving patient experiences in healthcare, the challenges faced in the industry, and the innovative solutions Upswing Health offers to streamline orthopedic care. The conversation highlights the significance of direct primary care, functional medicine, and the need for interoperability in healthcare systems. Dr. Schutzer emphasizes the entrepreneurial spirit required to address healthcare challenges and the importance of mentorship and effective communication in achieving success.

Chapters:

00:00 Introduction to Dr. Steve Schutzer and Upswing Health

02:49 Dr. Schutzer's Journey in Medicine

06:02 Mentorship and the Impact of Innovation in Orthopedics

08:51 Creating Centers of Excellence in Joint Replacement

11:55 Challenges in Healthcare and the Role of Legislation

14:50 Direct Pay and Direct Primary Care Innovations

18:01 Functional Medicine and Preventative Healthcare

21:06 The Future of Healthcare and Entrepreneurial Medicine

31:39 The Shift to Entrepreneurship

32:25 Building Centers of Excellence

34:48 Identifying the Ouch Moment

36:12 Innovative Solutions in Orthopedics

39:11 The Evolution of Orthopedic Management

41:28 The Vision for Upswing

44:20 Navigating Healthcare Challenges

47:30 Interoperability in Healthcare

51:27 The Future of Upswing

55:45 The Role of Employers in Healthcare

58:42 Marketing Strategies for Upswing

Guest Information:

• Guest's Name: Steve Schutzer 
• Guest's Title/Position: Co-Founder and Chief Medical Officer 
• Guest's Linkedin: https://www.linkedin.com/in/steve-schutzer-md-81616125/
• Company / Affiliation: Upswing Health https://upswinghealth.com/
• Guest's Bio: Steve Schutzer is an orthopedic surgeon specializing in adult hip and knee reconstruction, with decades of experience leading joint replacement programs and advancing value-based orthopedic care. He believes in the power of connected communities and digital technologies—especially in today’s accelerating AI environment—working alongside compassionate human caregivers to solve complex medical challenges. Recognized as a focused, innovative, and visionary healthcare physician leader and strategist, Steve has an enduring obsession with improving the patient experience.

Takeaways:

• Dr. Schutzer's journey reflects the unpredictability of career paths.
• The importance of mentorship in shaping a physician's career.
• Building centers of excellence can significantly improve patient care.
• Healthcare challenges are often rooted in financial disincentives.
• Direct primary care offers a promising alternative to traditional models.
• Functional medicine focuses on prevention and holistic care.
• Upswing Health aims to provide quick access to orthopedic care.
• Interoperability in healthcare is crucial for better patient outcomes.
• The rise of early onset cancers highlights the need for preventive care.
• Entrepreneurship in healthcare requires resilience and adaptability.

In this episode of The Healthy Enterprise, Jessicca Rege shares her groundbreaking work in cancer research at Sus Clinicals, where her team uses genetically modified “Oncopigs” to bridge the gap between preclinical and clinical trials. She discusses her path from academia to industry, her dual role as Chief Medical Officer at OncoScope AI, and her commitment to pushing the boundaries of oncology through innovative research, AI integration, and precision medicine. Jessicca also opens up about overcoming imposter syndrome, navigating the challenges of being a female leader, and mentoring the next generation of women in science. The conversation explores Sus Clinicals’ growth strategies in large animal research and offers inspiring insights for aspiring leaders on resilience, vision, and questioning the status quo.

Chapters:

00:00 Introduction to Jessicca Rege and Sus Clinicals

07:30 The Oncopig Model: Revolutionizing Cancer Research

18:04 The Journey of a Mutant Pig Farmer

24:51 AI in Cancer Research and Future Directions

27:14 Introduction to OncoScope AI and Leadership Roles

28:36 Disruptive Leadership and Questioning the Status Quo

30:45 Navigating Imposter Syndrome as a CEO

32:42 The Challenges of Being a Female Leader

35:41 Cultivating Future Female Leaders

39:03 Steering Growth at Sus Clinicals

41:33 Innovative Approaches in Large Animal Research

45:34 Future Outlook and Goals for Sus Clinicals

49:25 Advice for Aspiring Leaders

Guest Information:

• Guest's Name: Jessicca Rege
• Guest's Title/Position: Chief Executive Officer
• Guest's Linkedin: https://www.linkedin.com/in/jessiccarege/
• Company / Affiliation: Sus Clinicals https://susclinicals.com/
• Guest's Bio: Jessicca Rege is a pharmaceutical executive with extensive experience in oncology drug development, from pre-IND through commercialization. She has led R&D, regulatory, and medical affairs teams in both large pharma and biotech, guided in-licensing and acquisition strategies, and worked closely with global regulatory authorities. Jessica is also a trusted voice with investors, scientific leaders, and industry partners, advancing innovative cancer therapies worldwide.

Takeaways:

• Jessicca Rege is passionate about transformative research in cancer.
• Sus Clinicals uses genetically modified pigs to advance cancer research.
• The Oncopig model allows for testing efficacy, safety, and metabolic effects.
• Cancer patients are often more knowledgeable about their conditions than expected.
• Jessica emphasizes the importance of empathy in patient care.
• The Oncopig model can replicate human cancers on demand.
• Precision medicine is becoming the standard in oncology.
• AI is being utilized in cancer research for systematic literature reviews.
• Jessica's journey reflects a commitment to improving patient outcomes.
• The integration of various medical professionals is crucial in cancer treatment. I am known as a disruptive leader.
• Imposter syndrome is always going to be with us.
• We want to continue to build models that enable researchers.
• We have a hundred percent success rate in being able to induce tumors.
• We believe the uptake is coming in.
• We could sell each of our different models to a different CRO.
• We hope to become a profitable company by 2027.
• You get more nos than you get yeses.
• I love the impact that I'm making on the teams.

In this episode, Braden Pan, CEO and founder of Resolve, discusses the significant issue of medical debt in America, which affects one in three individuals and is a leading cause of bankruptcy. He shares his personal journey that led him to create Resolve, a company dedicated to helping patients navigate and reduce their medical bills. Braden elaborates on the challenges of founding a startup, the integration of AI in their processes, and the importance of negotiating with hospitals. He also emphasizes the need for co-founders and the evolution of his leadership style as the company grows. The conversation highlights the future of Resolve, focusing on B2B expansion and the broader goal of addressing various types of debt.

Chapters:
00:00 Introduction to Resolve and Medical Debt
03:11 Braden's Personal Journey and Founding Resolve
06:11 Navigating the Complexities of Medical Billing
09:05 The Role of AI in Medical Billing Solutions
12:05 Understanding Hospital Billing Practices
14:47 The Impact of Medical Debt on Patients
17:58 Marketing Strategies and Patient Success Stories
20:53 Future Directions for Resolve
22:37 Navigating Financial Aid in Healthcare
25:22 The Role of a Founder and CEO
30:40 Shifting Business Strategies and Messaging
32:14 Future Aspirations and Goals
35:25 Leadership Evolution and Team Dynamics
39:34 Advice for Aspiring Founders and Co-founders

Guest Information:

• Guest's Name: Braden Pan
• Guest's Title/Position: CEO and Founder
• Guest's Linkedin: https://www.linkedin.com/in/bradenpan/
• Company / Affiliation: Resolve https://www.resolvemedicalbills.com/
• Guest's Bio: The idea for Resolve was sparked in 2016, when founder Braden Pan received an outrageous hospital bill for a brief, 15-minute consultation. Frustrated by the complex and opaque billing process, Braden set out to find a better way. That experience became the foundation for Resolve—a company dedicated to helping Americans fight back against unfair medical bills. Since then, Resolve has tackled all types of healthcare billing challenges, partnering with experts across the healthcare ecosystem to reduce financial stress and bring greater transparency to the system.

Takeaways:

• Medical debt is a massive issue affecting many Americans.
• Resolve has saved patients over $55 million on medical bills.
• Braden's personal experience with medical debt inspired him to start Resolve.
• The healthcare system is complex and often designed to confuse patients.
• AI is being integrated into Resolve's processes to improve efficiency.
• Hospitals often prefer working with Resolve to lower their collection costs.
• Financial aid programs exist but are underutilized by patients.
• Braden emphasizes the importance of having a co-founder.
• Leadership evolves over time, especially in a startup environment.
• The future of Resolve includes expanding services to address all types of debt.